1.Human albumin administration in critically ill patients: systematic review of randomised controlled trials. Cochrane Injuries Group Albumin Reviewers. BMJ 1998;317:235–40.
2.Alderson, P, Bunn, F, Lefebvre, C, et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev. 2004;(4):CD001208.
3.Finfer, S, Bellomo, R, Boyce, N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350:2247–56.
4.McIntyre, LA, Fergusson, D, Cook, DJ, et al. Resuscitating patients with early severe sepsis: a Canadian multicentre observational study. Can J Anaesth 2007;54:790–8.
5.Vincent, JL, Moreno, R, Takala, J, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ/dysfunction/failure. On behalf of the Working Group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707–10.
6.Strehlow, MC, Emond, SD, Shapiro, NI, et al. National study of emergency department visits for sepsis, 1992 to 2001. Ann Emerg Med. 2006;48:326–31.
7.Martin, GS, Mannino, DM, Eaton, S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546–54.
8.Angus, DC, Linde-Zwirble, WT, Lidicker, J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303–10.
9.Green, RS, Djogovic, D, Gray, S, et al. Canadian Association of Emergency Physicians Sepsis Guidelines: the optimal management of severe sepsis in Canadian emergency departments. CJEM 2008;10:443–59.
10.Dellinger, RP, Levy, MM, Carlet, JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296–327.
11.Green, RS, Hall, RI. Con: starches are not preferable to albumin during cardiac surgery: a contrary opinion. J Cardiothorac Vasc Anesth 2008;22:485–91.
12.Traylor, RJ, Pearl, RG. Crystalloid versus colloid versus colloid: all colloids are not created equal. Anesth Analg 1996;83:209–12.
13.Imm, A, Carlson, RW. Fluid resuscitation in circulatory shock. Crit Care Clin 1993;9:313–33.
14.Ross, AD, Angaran, DM. Colloids vs. crystalloids — a continuing controversy. Drug Intell Clin Pharm 1984;18:202–12.
15.Vincent, JL, Navickis, RJ, Wilkes, MM. Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials. Crit Care Med 2004;32:2029–2038.
16.Wilkes, MM, Navickis, RJ. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001;135:149–64.
17.Haynes, GR, Navickis, RJ, Wilkes, MM. Albumin administration — what is the evidence of clinical benefit? A systematic review of randomized controlled trials. Eur J Anaesthesiol 2003;20:771–93.
18.Choi, PT, Yip, G, Quinonez, LG, et al. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 1999;27:200–10.
19.Dieterich, HJ. Recent developments in European colloid solutions. J Trauma 2003;54(Suppl):S26–30.
20.Schortgen, F, Deye, N, Brochard, L. Preferred plasma volume expanders for critically ill patients: results of an international survey. Intensive Care Med 2004;30:2222–9.
21.Boldt, J. Volume therapy in cardiac surgery: Are Americans different from Europeans? J Cardiothorac Vasc Anesth 2006;20:98–105.
22.Schortgen, F, Lacherade, JC, Bruneel, F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001;357:911–6.
23.The NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283–97.